SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 432.00
arrow_upward
+1.69%(+7.20) 1D
Oct 6, 2:18:18 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 430.60
High
SEK 435.20
Low
SEK 429.20
Mkt. cap
154.50B
Avg. vol.
265.10K
Volume
55.17K
P/E ratio
115.38
52-wk high
SEK 487.00
52-wk low
SEK 293.60
EPS
SEK 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEK 430.60
High
SEK 435.20
Low
SEK 429.20
Mkt. cap
154.50B
Avg. vol.
265.10K
Volume
55.17K
P/E ratio
115.38
52-wk high
SEK 487.00
52-wk low
SEK 293.60
EPS
SEK 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
Business Wire
·
1 hour ago
Everspin Technologies to Ring Opening Bell in Celebration of 10-Year Nasdaq Anniversary
The Manila Times
·
37 minutes ago
ONAR Appoints Audit Chair Kelly Anderson, Former Public-Company CFO and Veteran of More Than 400 Acquisitions, as Interim Chief Financial Officer to Lead Nasdaq Uplist Preparation
Stock Titan
·
22 minutes ago
AI agents have no checkout path at 97 of America's 100 largest retailers
CNN
·
3 hours ago
Wall Street is booming. Surging yields could shake things up
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)